NDC Active Ingredient Bosentan

  1. Home
  2. NDC Active Ingredient Index
  3. Bosentan

Active Ingredient Information

What is Bosentan?

A sulfonamide and pyrimidine derivative that acts as a dual endothelin receptor antagonist used to manage PULMONARY HYPERTENSION and SYSTEMIC SCLEROSIS.

What is the usage for Bosentan?

Bosentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, thereby helping to decrease the blood pressure in the lungs, slow the worsening of symptoms from the disease, and improve your ability to exercise.

How many products in the NDC database contain Bosentan?

The NDC database has 30 products with the active ingredient Bosentan. The following table lists all the products that have this active ingredient.

NDC Products with Bosentan

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0591-2511Proprietary Name: Bosentan BosentanTablet, Film CoatedOralActavis Pharma, Inc.ACTIVE
0591-2511Proprietary Name: BosentanTablet, Film CoatedActavis Pharma, Inc.ACTIVE
0591-2511Proprietary Name: Bosentan BosentanTablet, Film CoatedOralActavis Pharma, Inc.ACTIVE
0591-2511Proprietary Name: BosentanTablet, Film CoatedActavis Pharma, Inc.ACTIVE
0591-2512Proprietary Name: Bosentan BosentanTablet, Film CoatedOralActavis Pharma, Inc.ACTIVE
0591-2512Proprietary Name: BosentanTablet, Film CoatedActavis Pharma, Inc.ACTIVE
0591-2512Proprietary Name: Bosentan BosentanTablet, Film CoatedOralActavis Pharma, Inc.ACTIVE
0591-2512Proprietary Name: BosentanTablet, Film CoatedActavis Pharma, Inc.ACTIVE
14501-0041Proprietary Name: BosentanPowderMsn Laboratories Private LimitedACTIVE
47335-038Proprietary Name: Bosentan BosentanTablet, Film CoatedOralSun Pharmaceutical Industries, Inc.ACTIVE
47335-039Proprietary Name: Bosentan BosentanTablet, Film CoatedOralSun Pharmaceutical Industries, Inc.ACTIVE
53104-7703Proprietary Name: BosentanPowderCipla Ltd.ACTIVE
58032-2016Proprietary Name: Bosentan MonohydratePowderNeuland Laboratories LimitedACTIVE
65015-753Proprietary Name: BosentanPowderMylan Laboratories LimitedACTIVE
65015-770Proprietary Name: BosentanPowderMylan Laboratories LimitedACTIVE
65372-1184Proprietary Name: Bosentan MonohydratePowderJubilant Pharmova LimitedACTIVE
65691-0084Proprietary Name: Bosentan MonohydratePowderCadila Pharmaceuticals LimitedACTIVE
65841-176Proprietary Name: Bosentan MonohydratePowderCadila Healthcare LimitedACTIVE
65862-796Proprietary Name: Bosentan MonohydratePowderAurobindo Pharma LimitedACTIVE
66039-870Proprietary Name: BosentanPowderGlenmark Life Sciences LimitedACTIVE
66215-101Proprietary Name: Tracleer BosentanTablet, Film CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-102Proprietary Name: Tracleer BosentanTablet, Film CoatedOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-103Proprietary Name: Tracleer BosentanTablet, For SuspensionOralActelion Pharmaceuticals Us, Inc.ACTIVE
66215-232Proprietary Name: Tracleer BosentanTablet, For SuspensionOralActelion Pharmaceuticals Us, Inc.ACTIVE
68382-446Proprietary Name: Bosentan BosentanTablet, CoatedOralZydus Pharmaceuticals Usa Inc.ACTIVE
68382-447Proprietary Name: Bosentan BosentanTablet, CoatedOralZydus Pharmaceuticals Usa Inc.ACTIVE
69037-0005Proprietary Name: Bosentan MonohydratePowderHonour Lab LimitedACTIVE
70771-1017Proprietary Name: Bosentan BosentanTabletOralZydus Lifesciences LimitedACTIVE
70771-1018Proprietary Name: Bosentan BosentanTabletOralZydus Lifesciences LimitedACTIVE
82245-0104Proprietary Name: BosentanPowderViyash Life Sciences Private LimitedACTIVE
<